S-3 filed Apr 27, 2026 at 17:00 ET
Lifeward Ltd. filed an S-3 registration statement on April 27, 2026, registering 7,256,474 ordinary shares for resale by selling shareholders Oramed Pharmaceuticals and Creative Value Capital LP. These shares were issued in connection with the strategic acquisition of Oratech that closed on March 25, 2026. The company will not receive any proceeds, and the shares represent approximately 261% of current shares outstanding, creating a massive potential overhang. The company's auditor has expressed substantial doubt about its ability to continue as a going concern.